Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Sonam Mehta
Healthcare Resource Utilization and Associated Costs in Patients With Advanced Melanoma Receiving First-Line Ipilimumab
Journal of Cancer Therapy
Related publications
Hospitalization and Emergency Department Utilization in Patients With Advanced Melanoma Receiving Pembrolizumab vs. Ipilimumab Plus Nivolumab in US Academic Centers
Journal of Medical Economics
Health Policy
Healthcare Resource Utilization and Costs Associated With Patients Prescribed Afatinib or Erlotinib as First-Line Therapy for EGFR Mutation-Positive NSCLC in the United States
Journal of Medical Economics
Health Policy
Health Care Resource Utilization Among Advanced Melanoma Patients in Europe
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cost-Effectiveness of Nivolumab in Combination With Ipilimumab in First-Line Treatment of Advanced Melanoma in Sweden
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Real-World Productivity, Healthcare Resource Utilization (Hru), and Quality of Life (Qol) in Patients With First-Line Advanced Gastric Cancer (Agc) in Korea and Japan
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Healthcare Costs and Resource Utilization in Patients With Multiple Sclerosis Relapses Treated With H.P. Acthar Gel®
Advances in Therapy
Medicine
Pharmacology
Pgi15 - Healthcare Resource Utilization (Hcru) in Metastatic or Unresectable Gastric or Gastroesophageal Junction Cancer Patients Receiving Second-Line Treatment
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
EXPRESS: Treatment Patterns, Healthcare Resource Utilization, and Healthcare Costs Among Patients With Pulmonary Arterial Hypertension in a Real-World US Database
Pulmonary Circulation
Pulmonary
Respiratory Medicine
Pnd94 - A Retrospective Database Analysis of Healthcare Resource Utilization and Associated Costs Among Patient Treated With Rufinamide in Uk
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental